Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT

被引：4

作者：

Bohl, S. ^{[1
]}

von Harsdorf, S. ^{[1
]}

Mulaw, M. ^{[1
]}

Hofmann, S. ^{[1
]}

Babiak, A. ^{[1
]}

Maier, C. P. ^{[1
]}

Schnell, J. ^{[1
]}

Huetter-Kroenke, L-M ^{[1
]}

Scholl, K. ^{[1
]}

Wais, V. ^{[1
]}

Schlenk, R. F. ^{[1
]}

Bullinger, L. ^{[1
]}

Ringhoffer, M. ^{[1
]}

Doehner, H. ^{[1
]}

Bunjes, D. ^{[1
]}

Bommer, M. ^{[1
]}

Kuchenbauer, F. ^{[1
]}

机构：

[1] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

来源：

BONE MARROW TRANSPLANTATION | 2016年 / 51卷 / 07期

关键词：

ACUTE MYELOID-LEUKEMIA; STEM-CELL TRANSPLANTATION; CHEMOTHERAPY; RELAPSE;

D O I：

10.1038/bmt.2016.4

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：991 / 993

页数：3

共 10 条

[1] Au WY, 1999, HEMATOL ONCOL, V17, P45, DOI 10.1002/(SICI)1099-1069(199906)17:2<45::AID-HON641>3.0.CO
[2] 2-6
[3] Neoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantation
Bommer, Martin
von Harsdorf, Stephanie
Doehner, Hartmut
Bunjes, Donald
Ringhoffer, Mark
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (11): : 1969 - 1972
[4] Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Doehner, Hartmut
Estey, Elihu H.
Amadori, Sergio
Appelbaum, Frederick R.
Buechner, Thomas
Burnett, Alan K.
Dombret, Herve
Fenaux, Pierre
Grimwade, David
Larson, Richard A.
Lo-Coco, Francesco
Naoe, Tomoki
Niederwieser, Dietger
Ossenkoppele, Gert J.
Sanz, Miguel A.
Sierra, Jorge
Tallman, Martin S.
Loewenberg, Bob
Bloomfield, Clara D.
[J]. BLOOD, 2010, 115 (03) : 453 - 474
[5] Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome
Goyal, S. D.
Zhang, M-J
Wang, H-L
Akpek, G.
Copelan, E. A.
Freytes, C.
Gale, R. P.
Hamadani, M.
Inamoto, Y.
Kamble, R. T.
Lazarus, H. M.
Marks, D. I.
Nishihori, T.
Olsson, R. F.
Reshef, R.
Ritchie, D. S.
Saber, W.
Savani, B. N.
Seber, A.
Shea, T. C.
Tallman, M. S.
Wirk, B.
Bunjes, D. W.
Devine, S. M.
de Lima, M.
Weisdorf, D. J.
Uy, G. L.
[J]. BONE MARROW TRANSPLANTATION, 2015, 50 (08) : 1057 - 1062
[6] Post-remission therapy for acute myeloid leukemia
Schlenk, Richard F.
[J]. HAEMATOLOGICA, 2014, 99 (11) : 1663 - 1670
[7] Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome
Schmid, C
Schleuning, M
Ledderose, G
Tischer, J
Kolb, HJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5675 - 5687
[8] High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission
Schmid, C.
Schleuning, M.
Hentrich, M.
Markl, G. E.
Gerbitz, A.
Tischer, J.
Ledderose, G.
Oruzio, D.
Hiddemann, W.
Kolb, H-J
[J]. BONE MARROW TRANSPLANTATION, 2008, 41 (08) : 721 - 727
[9] Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
Schmid, Christoph
Schleuning, Michael
Schwerdtfeger, Rainer
Hertenstein, Bernd
Mischak-Weissinger, Eva
Bunjes, Donald
v. Harsdorf, Stephanie
Scheid, Christoph
Holtick, Udo
Greinix, Hildegard
Keil, Felix
Schneider, Barbara
Sandherr, Michael
Bug, Gesine
Tischer, Johanna
Ledderose, Georg
Hallek, Michael
Hiddemann, Wolfgang
Kolb, Hans-Jochem
[J]. BLOOD, 2006, 108 (03) : 1092 - 1099
[10] Extramedullary Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: An Easily Overlooked but Significant Pattern of Relapse
Yoshihara, Satoshi
Ando, Toshihiko
Ogawa, Hiroyasu
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (12) : 1800 - 1807

← 1 →